How do I contact Geert-Jan Mulder?

Geert-Jan Mulder, Managing Partner at Forbion, can be reached by email. The verified email address is listed on this page.

What is Geert-Jan Mulder's email address?

Geert-Jan Mulder's email address uses the forbion.com domain (shown as *****@forbion.com until revealed).

What does Geert-Jan Mulder invest in?

Geert-Jan Mulder backs Health tech and SaaS companies at Series A and Seed, typically writing €92k–€4.6M cheques.

How do I cold email Geert-Jan Mulder?

Geert-Jan Mulder backs Health tech and SaaS companies at Series A and Seed, writing €92k–€4.6M cheques. A concise cold email that leads with relevant traction and one specific ask, sent to the verified address on this page, is the most direct way to reach Geert-Jan.

Where is Geert-Jan Mulder based?

Geert-Jan Mulder is based in Naarden, Netherlands and works at Forbion.

Geert-Jan Mulder Email & Contact Information

Managing Partner @ Forbion

Show Geert-Jan's email

Geert-Jan Mulder Location

Naarden, Netherlands

Geert-Jan Mulder Investing

Managing Partner at Managing Partner

Stages: Series A, Seed
Sectors: Health tech, SaaS
Cheque size: €92k–€4.6M
Freshness: Verified 1mo ago

Geert-Jan Mulder Summary

Geert-Jan Mulder, based in Naarden, Netherlands, is a Managing Partner at Forbion. Geert-Jan Mulder invests in Health tech and SaaS at Series A and Seed, writing €92k–€4.6M cheques. Geert-Jan Mulder's verified email and contact details are available on Mintround.

How to cold email Geert-Jan Mulder

Geert-Jan Mulder, Forbion in Naarden, Netherlands, backs Health tech and SaaS companies at Series A and Seed, writing €92k–€4.6M cheques. Here's how to get a reply when you cold email Geert-Jan:

Subject line: name your company and one metric that matters to Health tech and SaaS, not “quick chat”.
First line: your strongest traction, the real numbers, not adjectives.
One ask: a 20-minute call with a date range. Keep it under 150 words.
Send it to Geert-Jan's verified address below. No warm intro required.

Show Geert-Jan's email

Notable investments

CitryllSeries B · $90M · 2024
Mariana OncologySeries B · $180M · 2023
Complement TherapeuticsSeries A · $79M · 2023
PrileniaSeries B · $43M · 2021
AM PharmaSeries Unknown · $25M · 2020
Enterprise TherapeuticsSeries B · $41M · 2018
Exosome DiagnosticsSeries C · $30M · 2017
Genetix Biotherapeutics Inc.Series D · $60M · 2012

Frequently co-invests with

Alexander MaywegVersant VenturesAnne HorganCambridge Innovation CapitalDan BeckerAccess BiotechnologyDavid MorrisDmitrij HristodorovForbionEdward Van Wezel (BGV (BioGeneration Ventures))Felice Verduyn - van WeegenEQT Life SciencesFlorian MüllershausenNovartis Venture FundIsabelle de CremouxSeventure PartnersJosh ResnickJoël Jean-MairetYsios CapitalKevin BittermanAtlas Venture

Geert-Jan Mulder's colleagues at Forbion

Rogier RooswinkelPartner, Forbion

Sander SlootwegManaging Partner, Forbion

Wouter JoustraGeneral Partner, Forbion

Antoine Boulanger PietteAssociate, Forbion

Audrey CacalySenior Associate, Forbion

Dmitrij HristodorovPartner, Forbion

Dirk KerstenGeneral Partner, Forbion

Holger ReithingerGeneral Partner, Forbion

Jasper BosGeneral Partner, Forbion

Marco BoorsmaGeneral Partner, Forbion

Martien van OschManaging Partner, Forbion

Nanna LuneborgGeneral Partner, Forbion

See all 13 at Forbion →

Similar investors

Diede BrunenSenior Associate, BGV (BioGeneration Ventures)

Antoine Boulanger PietteAssociate, Forbion

Robin van BoxselPartner, FORWARD.one

Clement SalqueAnalyst, Bioqube Ventures